In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome

Francesco D'Alo', Livio Pagano, Stefan Hohaus, Valerio De Stefano, Elisa Cupelli, Luana Fianchi, Marianna Criscuolo, Emiliano Fabiani, Ilaria Zangrilli, Giulia Falconi

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

Abstract

Thrombocytopenia is a severe complication for patients with myelodysplastic syndrome (MDS). Eltrombopag increases platelet count in MDS patients but its combination with azacitidine elicited controversial results. We aimed to quantify the colony forming units of megakaryocytes (CFU-Mk) obtained from CD34+ bone marrow cells isolated from patients with MDS and from healthy donors that were cultured in vitro in the presence or absence of azacitidine and with or without the sequential addition of eltrombopag to the culture medium. CD34+ bone marrow cells from 6 MDS patients and 3 controls were expanded in vitro and cultured for 3 days with or without azacitidine. Subsequently, a CFU-Mk assay was performed in presence or absence of eltrombopag. The addition of eltrombopag in the CFU-Mk assay after mock treatment of CD34+ cells increased the number of CFU-Mk in both controls and patients. On the contrary, using azacitidine pretreated CD34+ cells, eltrombopag minimally increased CFU-Mk in controls and produced heterogeneous response in MDS patients with no change in two patients and CFU-Mk increase in four patients. In vitro CFU-Mk assay suggest that some MDS patients are likely to benefit from the sequential addition of eltrombopag after azacitidine treatment, in the context of a personalized medicine.
Lingua originaleEnglish
pagine (da-a)1-5
Numero di pagine5
RivistaPLATELETS
Volume2020
DOI
Stato di pubblicazionePubblicato - 2020

Keywords

  • megakaryopoiesis
  • myelodysplastic syndrome

Fingerprint

Entra nei temi di ricerca di 'In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome'. Insieme formano una fingerprint unica.

Cita questo